Literature DB >> 6292984

Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects.

E P Bonetti, L Pieri, R Cumin, R Schaffner, M Pieri, E R Gamzu, R K Müller, W Haefely.   

Abstract

In neurological and behavioral studies in mice, rats, dogs and squirrel monkeys, the imidazobenzodiazepinone Ro 15-1788 acted as a potent benzodiazepine antagonist. The antagonistic activity was both preventive and curative and seen at doses at which no intrinsic effects were detected. It was highly selective in that it acted against CNS effects induced by benzodiazepines but not against those produced by other depressants, such as phenobarbitone, meprobamate, ethanol, and valproate. The onset of action was rapid even after oral administration. Depending on the animal species studied, the antagonistic effects lasted from a few hours to 1 day. The acute and subacute toxicity of Ro 15-1788 was found to be very low. Benzodiazepine-like effects were not seen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292984     DOI: 10.1007/bf00470579

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Continuous avoidance as a base-line for measuring behavioral effects of drugs.

Authors:  G A HEISE; E BOFF
Journal:  Psychopharmacologia       Date:  1962-10-05

2.  Behavioral effects of some psychopharmacological agents.

Authors:  L COOK; E WEIDLEY
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

Review 3.  Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.

Authors:  E Costa; A Guidotti; C C Mao
Journal:  Adv Biochem Psychopharmacol       Date:  1975

4.  Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.

Authors:  C Braestrup; R F Squires
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Diazepam receptor characterization: specific binding of a benzodiazepine to macromolecules in various areas of rat brain.

Authors:  H B Bosmann; K R Case; P DiStefano
Journal:  FEBS Lett       Date:  1977-10-15       Impact factor: 4.124

6.  [Assays on application and antagonizing of benzodiazepines in cattle (author's transl)].

Authors:  R Beglinger; B Hamza; P Heizmann; E Kyburz; W F Rehm
Journal:  Dtsch Tierarztl Wochenschr       Date:  1982-04-06

7.  Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.

Authors:  A Darragh; R Lambe; M Scully; I Brick; C O'Boyle; W W Downe
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

Review 8.  GABA-benzodiazepine-barbiturate receptor interactions.

Authors:  R W Olsen
Journal:  J Neurochem       Date:  1981-07       Impact factor: 5.372

Review 9.  Pharmacology of midazolam.

Authors:  L Pieri; R Schaffner; R Scherschlicht; P Polc; J Sepinwall; A Davidson; H Möhler; R Cumin; M Da Prada; W P Burkard; H H Keller; R K Müller; M Gerold; M Pieri; L Cook; W Haefely
Journal:  Arzneimittelforschung       Date:  1981

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  62 in total

1.  Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice.

Authors:  Wouter Koek; Charles P France; Martin A Javors
Journal:  Psychopharmacology (Berl)       Date:  2011-08-12       Impact factor: 4.530

2.  Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93,426: preliminary observations on psychotropic activity.

Authors:  T Duka; D N Stephens; W Krause; R Dorow
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Authors:  Lauren M Slosky; Yushi Bai; Krisztian Toth; Caroline Ray; Lauren K Rochelle; Alexandra Badea; Rahul Chandrasekhar; Vladimir M Pogorelov; Dennis M Abraham; Namratha Atluri; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick Maloney; Hong Yuan; Zibo Li; William C Wetsel; Anthony B Pinkerton; Lawrence S Barak; Marc G Caron
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

Review 4.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

5.  "Anxiolytic" and "anxiogenic" benzodiazepines and beta-carbolines: effects on aggressive and social behavior in rats and squirrel monkeys.

Authors:  E M Weerts; W Tornatzky; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Prevention of the pro-aggressive effects of alcohol in rats and squirrel monkeys by benzodiazepine receptor antagonists.

Authors:  E M Weerts; W Tornatzky; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat.

Authors:  M H Thiébot; P Soubrié; M Hamon; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  The effects of compounds related to gamma-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: punished barpressing.

Authors:  S Quintero; S Henney; P Lawson; J Mellanby; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Benzodiazepine receptors mediate regional blood flow changes in the living human brain.

Authors:  E Matthew; P Andreason; K Pettigrew; R E Carson; P Herscovitch; R Cohen; C King; C E Johanson; D J Greenblatt; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.

Authors:  J W Mandema; M T Kuck; M Danhof
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.